FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313487991> ?p ?o ?g. }

• W4313487991 endingPage "990" @default.
• W4313487991 startingPage "983" @default.
• W4313487991 abstract "INTRODUCTION: Fibrosis stage is the strongest predictor of mortality in patients with nonalcoholic fatty liver disease (NAFLD). There is currently no approved therapy that specifically targets fibrosis. This study aims to assess the effect of endoscopic gastric plication on hepatic fibrosis in patients with underlying NAFLD. METHODS: This is a retrospective analysis of prospectively collected registry of patients with obesity and NAFLD with clinically significant hepatic fibrosis (≥F2) who underwent endoscopic gastric plication. Full-thickness plications were placed in the gastric body using a commercially available platform to reduce the gastric volume. The primary outcome included various noninvasive tests (NITs) of hepatic fibrosis based on clinical chemistry and/or imaging. The secondary outcomes included NITs of hepatic steatosis, other metabolic outcomes, including hemoglobin A1c, insulin resistance, and total weight loss (TWL), and adverse events. RESULTS: Forty-five patients (age 51 ± 13 years and body mass index 40.7 ± 6.9 kg/m 2 ) were included. All patients underwent endoscopic gastric plication successfully. At 6–12 months, there were significant reductions in biochemistries (alanine aminotransferase: 49.7 ± 36.8 U/L to 24.2 ± 12.0 U/L [ P < 0.0001], aspartate aminotransferase: 39.1 ± 24.1 U/L to 24.1 ± 10.0 U/L [ P < 0.0001]), composite fibrosis score (NAFLD fibrosis score: 0.48 ± 1.51 to −1.18 ± 1.56 [ P < 0.0001], fibrosis-4 index: 1.4 ± 1.2 to 1.2 ± 0.7 [ P = 0.03]), and imaging-based markers of fibrosis (vibration-controlled transient elastography: 13.9 ± 7.5 kPa to 8.9 ± 4.8 kPa ( P < 0.0001) and Agile 3+: 0.53 ± 0.28 to 0.37 ± 0.28 [ P = 0.001]). There were significant reductions in controlled attenuation parameter, Homeostatic Model Assessment for Insulin Resistance, and hemoglobin A1c ( P < 0.05 for all). At 12 months, patients experienced 15.5% ± 7.9% TWL, with 63% reaching at least 10% TWL. DISCUSSION: Endoscopic gastric plication seems effective at treating NAFLD, with significant reduction in NITs of hepatic fibrosis even in patients with cirrhosis." @default.
• W4313487991 created "2023-01-06" @default.
• W4313487991 creator A5036658494 @default.
• W4313487991 creator A5051425820 @default.
• W4313487991 creator A5069487850 @default.
• W4313487991 date "2022-12-23" @default.
• W4313487991 modified "2023-10-09" @default.
• W4313487991 title "Regression of Hepatic Fibrosis After Endoscopic Gastric Plication in Nonalcoholic Fatty Liver Disease" @default.
• W4313487991 cites W1576711958 @default.
• W4313487991 cites W1908780918 @default.
• W4313487991 cites W1983417944 @default.
• W4313487991 cites W1998092898 @default.
• W4313487991 cites W2008335517 @default.
• W4313487991 cites W2067096633 @default.
• W4313487991 cites W2091106363 @default.
• W4313487991 cites W2093182588 @default.
• W4313487991 cites W2093467790 @default.
• W4313487991 cites W2093587125 @default.
• W4313487991 cites W2106768039 @default.
• W4313487991 cites W2149962856 @default.
• W4313487991 cites W2157338541 @default.
• W4313487991 cites W2170740817 @default.
• W4313487991 cites W2213014172 @default.
• W4313487991 cites W2216671742 @default.
• W4313487991 cites W2283809486 @default.
• W4313487991 cites W2431852073 @default.
• W4313487991 cites W2539985532 @default.
• W4313487991 cites W2587073664 @default.
• W4313487991 cites W2605866155 @default.
• W4313487991 cites W2734724639 @default.
• W4313487991 cites W2743667261 @default.
• W4313487991 cites W2759997926 @default.
• W4313487991 cites W2770129291 @default.
• W4313487991 cites W2891159865 @default.
• W4313487991 cites W2892053943 @default.
• W4313487991 cites W2896985838 @default.
• W4313487991 cites W2897450526 @default.
• W4313487991 cites W2949738090 @default.
• W4313487991 cites W2969317022 @default.
• W4313487991 cites W2985579744 @default.
• W4313487991 cites W2993083975 @default.
• W4313487991 cites W3003361050 @default.
• W4313487991 cites W3021927711 @default.
• W4313487991 cites W3022793136 @default.
• W4313487991 cites W3034346518 @default.
• W4313487991 cites W3081087626 @default.
• W4313487991 cites W3107186554 @default.
• W4313487991 cites W3126634223 @default.
• W4313487991 cites W3137033928 @default.
• W4313487991 cites W3201482376 @default.
• W4313487991 cites W3205069513 @default.
• W4313487991 cites W3208671080 @default.
• W4313487991 cites W4207059610 @default.
• W4313487991 cites W4221073102 @default.
• W4313487991 cites W4226334091 @default.
• W4313487991 doi "https://doi.org/10.14309/ajg.0000000000002087" @default.
• W4313487991 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36597405" @default.
• W4313487991 hasPublicationYear "2022" @default.
• W4313487991 type Work @default.
• W4313487991 citedByCount "3" @default.
• W4313487991 countsByYear W43134879912023 @default.
• W4313487991 crossrefType "journal-article" @default.
• W4313487991 hasAuthorship W4313487991A5036658494 @default.
• W4313487991 hasAuthorship W4313487991A5051425820 @default.
• W4313487991 hasAuthorship W4313487991A5069487850 @default.
• W4313487991 hasConcept C126322002 @default.
• W4313487991 hasConcept C2776175330 @default.
• W4313487991 hasConcept C2776954865 @default.
• W4313487991 hasConcept C2778772119 @default.
• W4313487991 hasConcept C2779134260 @default.
• W4313487991 hasConcept C2780221984 @default.
• W4313487991 hasConcept C2780559512 @default.
• W4313487991 hasConcept C2780578515 @default.
• W4313487991 hasConcept C2780826214 @default.
• W4313487991 hasConcept C2993667909 @default.
• W4313487991 hasConcept C2994217296 @default.
• W4313487991 hasConcept C41260117 @default.
• W4313487991 hasConcept C511355011 @default.
• W4313487991 hasConcept C71924100 @default.
• W4313487991 hasConcept C90924648 @default.
• W4313487991 hasConceptScore W4313487991C126322002 @default.
• W4313487991 hasConceptScore W4313487991C2776175330 @default.
• W4313487991 hasConceptScore W4313487991C2776954865 @default.
• W4313487991 hasConceptScore W4313487991C2778772119 @default.
• W4313487991 hasConceptScore W4313487991C2779134260 @default.
• W4313487991 hasConceptScore W4313487991C2780221984 @default.
• W4313487991 hasConceptScore W4313487991C2780559512 @default.
• W4313487991 hasConceptScore W4313487991C2780578515 @default.
• W4313487991 hasConceptScore W4313487991C2780826214 @default.
• W4313487991 hasConceptScore W4313487991C2993667909 @default.
• W4313487991 hasConceptScore W4313487991C2994217296 @default.
• W4313487991 hasConceptScore W4313487991C41260117 @default.
• W4313487991 hasConceptScore W4313487991C511355011 @default.
• W4313487991 hasConceptScore W4313487991C71924100 @default.
• W4313487991 hasConceptScore W4313487991C90924648 @default.
• W4313487991 hasIssue "6" @default.
• W4313487991 hasLocation W43134879911 @default.
• W4313487991 hasLocation W43134879912 @default.

• next